The New Frontier in Drug Development: Understanding Biologics and Small Molecules
Cloudbyz
MARCH 5, 2024
The choice between developing a biologic or a small molecule drug often depends on the nature of the disease target, the desired mechanism of action, and the feasibility of manufacturing and delivery. Monitoring and managing immunogenicity is a complex aspect of clinical trials for biologics.
77 
Let's personalize your content